EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Ethyl Acetate Extract of Phyllanthus emblica L. Alleviates Diabetic Nephropathy in a Murine Model of Diabetes

Cheng-Hsiu Lin, Chun-Ching Shih iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25126686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Cheng-Hsiu Lin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare, Fengyuan District, Taichung City 42055, Taiwan. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Plant Extracts, Phyllanthus emblica, Disease Models, Animal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology (now: National Science and Technology Council), Taipei, Taiwan, Ministry of Science and Technology (now: National Science and Technology Council), Taipei, Taiwan, ROC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oil-Gan is the fruit of the genus Phyllanthus emblica L. The fruits have excellent effects on health care and development values. There are many methods for the management of diabetic nephropathy (DN). However, there is a lack of effective drugs for treating DN throughout the disease course. The primary aim of this study was to examine the protective effects (including analyses of urine and blood, and inflammatory cytokine levels) and mechanisms of the ethyl acetate extract of P. emblica (EPE) on db/db mice, an animal model of diabetic nephropathy; the secondary aim was to examine the expression levels of p- protein kinase Cα (PKCα)/t-PKCα in the kidney and its downregulation of vascular endothelial growth factor (VEGF) and fibrosis gene transforming growth factor-β1 (TGF-β1) by Western blot analyses. Eight db/m mice were used as the control group. Forty db/db mice were randomly divided into five groups. Treatments included a vehicle, EPE1, EPE2, EPE3 (at doses of 100, 200, or 400 mg/kg EPE), or the comparative drug aminoguanidine for 8 weeks. After 8 weeks of treatment, the administration of EPE to db/db mice effectively controlled hyperglycemia and hyperinsulinemia by markedly lowering blood glucose, insulin, and glycosylated HbA1c levels. The administration of EPE to db/db mice decreased the levels of BUN and creatinine both in blood and urine and reduced urinary albumin excretion and the albumin creatine ratio (UACR) in urine. Moreover, EPE treatment decreased the blood levels of inflammatory cytokines, including kidney injury molecule-1 (KIM-1), C-reactive protein (CRP), and NLR family pyrin domain containing 3 (NLRP3). Our findings showed that EPE not only had antihyperglycemic effects but also improved renal function in db/db mice. A histological examination of the kidney by immunohistochemistry indicated that EPE can improve kidney function by ameliorating glomerular morphological damage following glomerular injury; alleviating proteinuria by upregulating the expression of nephrin, a biomarker of early glomerular damage; and inhibiting glomerular expansion and tubular fibrosis. Moreover, the administration of EPE to db/db mice increased the expression levels of p- PKCα/t-PKCα but decreased the expression levels of VEGF and renal fibrosis biomarkers (TGF-β1, collagen IV, p-Smad2, p-Smad3, and Smad4), as shown by Western blot analyses. These results implied that EPE as a supplement has a protective effect against renal dysfunction through the amelioration of insulin resistance as well as the suppression of nephritis and fibrosis in a DN model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesPlant ExtractsPhyllanthus emblicaDisease Models, AnimalDiabetes Mellitus, ExperimentalAnimalsMiceMaleAcetatesVascular Endothelial Growth Factor AKidneyTransforming Growth Factor beta1Protein Kinase C-alphaBlood Glucose

Stichwörter der Autor:innen

Phyllanthus emblica L.db/db micediabetic nephropathy

Substanzen

Plant ExtractsAcetatesethyl acetateVascular Endothelial Growth Factor ATransforming Growth Factor beta1Protein Kinase C-alphaBlood Glucose

Autor:innen und Institutionen

  • Department of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare, Fengyuan District, Taichung City 42055, Taiwan.
  • Department of Nursing, College of Nursing, Central Taiwan University of Science and Technology, No. 666 Buzih Road, Beitun District, Taichung City 406053, Taiwan.

ORCID-Profile: Chun-Ching Shih

Förderung

  • Ministry of Science and Technology (now: National Science and Technology Council), Taipei, Taiwan
  • Ministry of Science and Technology (now: National Science and Technology Council), Taipei, Taiwan, ROC

Zitieren

APA

Lin, C. H., & Shih, C. C. (2024). The Ethyl Acetate Extract of Phyllanthus emblica L. Alleviates Diabetic Nephropathy in a Murine Model of Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126686

Vancouver

Lin CH, Shih CC. The Ethyl Acetate Extract of Phyllanthus emblica L. Alleviates Diabetic Nephropathy in a Murine Model of Diabetes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126686

BibTeX
@article{Lin2024,
  author = {Lin, Cheng-Hsiu and Shih, Chun-Ching},
  title = {The Ethyl Acetate Extract of Phyllanthus emblica L. Alleviates Diabetic Nephropathy in a Murine Model of Diabetes},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25126686}
}
Kostenlos starten →